CLBZ · As filed with the SEC
Collab Z income statement, by quarter
The statement as Collab Z presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Operations (Unaudited) · USD
| USD | Q2 FY26 3 months ended Mar 31, 2026 | Q1 FY26 3 months ended Dec 31, 2025 | Q4 FY25 3 months ended Sep 30, 2025 |
|---|---|---|---|
| Revenue - related parties | 392,777 | 383,596 | — |
| Revenue | 386,172 | 99,647 | — |
| Total revenue | 778,949 | 483,243 | — |
| Cost of revenue | 119,941 | 77,367 | — |
| Gross profit | 659,008 | 405,876 | — |
| Operating expenses: | |||
| Sales and marketing | 141,881 | 59,920 | — |
| General and administrative | 335,977 | 261,837 | — |
| Total operating expenses | 477,858 | 321,757 | — |
| Income from operations | 181,150 | 84,119 | — |
| Other income (expense) | |||
| Interest income | 13,828 | 8,355 | — |
| Income on joint ventures | — | 2,238 | — |
| Loss on joint ventures | (2,754) | — | — |
| Total other income (expense) | 11,074 | 10,593 | — |
| Net income | 192,224 | 94,712 | — |
| Weighted average common shares outstanding | |||
| Basic | 5,091,391 | 5,120,898 | — |
| Diluted | 5,091,391 | 5,120,898 | — |
| Net income per common share | |||
| Basic | 0.03 | 0.01 | — |
| Diluted | 0.03 | 0.01 | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.